Compare DNLI & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNLI | AXTI |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2017 | 1998 |
| Metric | DNLI | AXTI |
|---|---|---|
| Price | $18.42 | $30.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | $35.82 | ★ $82.77 |
| AVG Volume (30 Days) | 1.3M | ★ 9.1M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $99,361,000.00 |
| Revenue This Year | N/A | $167.93 |
| Revenue Next Year | $204.90 | $111.50 |
| P/E Ratio | ★ N/A | $61.09 |
| Revenue Growth | N/A | ★ 31.09 |
| 52 Week Low | $15.34 | $8.84 |
| 52 Week High | $27.30 | $143.16 |
| Indicator | DNLI | AXTI |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 32.20 |
| Support Level | $18.24 | $22.59 |
| Resistance Level | $21.45 | $47.00 |
| Average True Range (ATR) | 0.94 | 5.24 |
| MACD | -0.10 | -0.64 |
| Stochastic Oscillator | 24.50 | 3.15 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.